Skip to main content
. 2022 Jul 14;2022:2960773. doi: 10.1155/2022/2960773

Figure 3.

Figure 3

miR-760 could target IDO1. (a) The IDO1 mRNA level in cells transfected with miR-760-mimics/miR-760-inhibit is tested via qRT-PCR. (b) The IDO1 protein level in cells transfected with miR-760-mimics/miR-760-inhibit is tested via WB. (c) The IDO1 level in tumor tissues of NSCLC patients is tested via qRT-PCR. (d) The correlation between IDO1 and miR-760 in tumor tissues of NSCLC patients is assessed via Pearson test. (e) Binding and mutation sites of miR-760 and IDO1. (f and g) Dual-luciferase reporter confirmed that miR-760 had target correlation with IDO1. ∗P < 0.05 and ∗∗∗P < 0.001.